Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · IEX Real-Time Price · USD
7.44
+0.32 (4.49%)
Jul 2, 2024, 4:30 PM EDT - Market closed
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $266.27 million as of July 2, 2024. Its market cap has decreased by -10.92% in one year.
Market Cap
266.27M
Enterprise Value
192.85M
1-Year Change
-10.92%
Ranking
Category
Stock Price
$7.44
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $183.30M to $266.27M, an increase of 45.26%. That is a compound annual growth rate of 10.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 254.80M | -21.91% |
| Dec 29, 2023 | 326.30M | 6.74% |
| Dec 30, 2022 | 305.70M | 48.33% |
| Dec 31, 2021 | 206.10M | -21.34% |
| Dec 31, 2020 | 262.00M | 42.94% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADC Therapeutics | 304.07M |
| Spok Holdings | 299.84M |
| SOPHiA GENETICS | 299.42M |
| Zynex | 296.14M |
| Nautilus Biotechnology | 293.12M |
| Immutep | 291.40M |
| Alimera Sciences | 291.28M |
| Opthea | 290.97M |